期刊文献+

哌仑西平眼部离子导入治疗近视的药效学研究 被引量:2

Study of the pharmacodynamics of pirenzepine iontophoresis for experimental myopia
在线阅读 下载PDF
导出
摘要 目的观察哌仑西平眼部离子导入治疗近视的药效,为哌仑西平的临床使用提供实验依据。方法出生3周的花色豚鼠81只,随机分为9组,其中7组以单眼眼睑缝合法建立形觉剥夺性近视模型。在进行近视诱导的同时,9个组别分别接受如下处理:3组进行形觉剥夺眼的哌仑西平电场促透(离子导入),其中包括高、中、低三种不同的电流强度(PIRx-MD);1组为形觉剥夺眼的空白对照组高电流强度离子导入(Vehicle0.3-MD);1组为无电场促透的哌仑西平局部滴眼(PIR-MD);1组为无电场促透的阿托品局部滴眼(At-ropine-MD);1组为单纯形觉剥夺对照组(Normal-MD);其余2组未建立形觉剥夺,作为对照。处理时间30d。检验指标包括屈光度、眼球前后径、眼球重量和组织病理学。结果Normal-MD和Vehicle0.3-MD组实验眼诱导出-4.64D和-4.33D的近视,哌仑西平离子导入的3组分别诱导出-2.15D、-0.17D、-1.30D的近视;Normal-MD组实验眼的眼球前后径在实验结束时较对照眼增加0.3mm,哌仑西平离子导入的3组分别增加-0.1mm、0mm、-0.1mm;Normal-MD组眼球重量较对照眼增加0.02g,哌仑西平离子导入的3组分别增加0g、0g、-0.02g。两者之间差异均有统计学意义。所有实验眼光镜病理检查未发现异常改变。结论哌仑西平眼部离子导入抑制实验性近视效果明显优于局部滴眼,和阿托品作用类似;同时不引起眼组织的病理改变。 Objective The purpose of the investigation was to examine the effect of pirenzepine iontophoresis on controlling experimental myopia and the possibility of injury to ocular tissues. Methods Three-week-old guinea pigs were monocularly deprived (MD) by lid-suture for a period of 30 days. During the 30 days, three of the MD groups received daily iontophoresis of pirenzepine (variable current intensity) (PIRx-MD); one group received daily iontophoresis of vehicle (Vehicle 0.3-MD). Control groups (PIR-MD, Atropine-MD, Normal-MD) were used to assess the effects of MD, the iontophoresis regimen, and drug effects. Retinoscopy, anterior/ posterior dimensions, and eye weight were measured and a histological examination was performed. Results In Normal-MD and Vehicle 0.3-MD guinea pigs, 30 days of MD produced -4.64 D and -4.33 D of axial myopia, respectively. In pirenzepine ion- tophoresis MD guinea pigs, 30 days of MD induced an axial myopia of only -2.15 D, -0.17 D and -1.30 D, respectively, The increments in anterior/posterior dimensions were -0.1 mm, 0 mm and -0.1 mm, respectively, in the three PIRx-MD groups, and 0.3 mm in the Normal-MD group. The increments in eye weight were 0 g, 0g and -0.02 g in the three PIRx-MD groups and 0.02 g in the Normal-MD group. Histological examination revealed no evidence of gross toxic effects. Conclusion Iontophoresis can enhance the corneal penetration of pirenzepine. Chronic administration of pirenzepine by iontophoresis can safely prevent experimentally induced myopia more effectively than topical instillation.
出处 《眼视光学杂志》 2008年第4期298-301,共4页 Chinese Journal of Optometry & Ophthalmology
基金 上海市科委基金资助项目(024319232)
关键词 哌仑西平 离子导入 近视眼 药效学 pirenzepine iontophoresis myopia pharmacody-namics
  • 相关文献

参考文献6

  • 1戴怡康,褚仁远.哌仑西平滴眼剂在兔房水中的药代动力学研究[J].眼视光学杂志,2002,4(4):228-229. 被引量:11
  • 2Sherman SM, Norton TT, Casagrande VA. Myopia in the lidsutured tree shrew[J]. Brain Res, 1977,124( 1 ) :154-157.
  • 3Cottriall CL, McBrien NA. The MI musearinie antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew[J]. Invest Ophthalmol Vis Sci, 1996,37(7) : 1368-1379.
  • 4Leech EM, Cottriall CL, Mcbrien NA. Pirenzepine prevents form deprivation myopia in a dose dependent manner [J]. Ophthahnic Physiol Opt, 1995,15(5) : 351-356.
  • 5Rickers M, Schaeffel F. Dose-dependent effects of intravitreal pirenzepine on deprivation myopia and lens-induced refractive errors in chicken[J]. Exp Eye Res, 1995,61 (4) :509-516.
  • 6Parkinson TM, Ferguson E, Febbraro S, et al. Tolerance of ocular iontophoresis in healthy volunteers [J]. J Ocul Pharmacol Ther, 2003,19(2) : 145-151.

二级参考文献2

  • 1Cottriall CL, Annies R, Brew J, et al. Pirenzepine reduces retinal acetylcholine and dopamine levels[J]. Proc Aust Neurosci Soc, 1999,10:55.
  • 2Cottriall CL, McBrien NA, Annies R, et al. Prevention of form deprivation myopia with pirenzepine: a study of drug delivery and distribution[J]. Ophthal Physiol Opt, 1999,4:327-335.

共引文献10

同被引文献42

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部